150 related articles for article (PubMed ID: 35331842)
1. Systemic exposure and urinary excretion of vanadium following perinatal subchronic exposure to vanadyl sulfate and sodium metavanadate via drinking water.
Waidyanatha S; Weber FX; Fallacara DM; Harrington JM; Levine K; Robinson VG; Sparrow BR; Stout MD; Fernando R; Hooth MJ; Xie G; Roberts GK
Toxicol Lett; 2022 May; 360():53-61. PubMed ID: 35331842
[TBL] [Abstract][Full Text] [Related]
2. Internal dose of vanadium in rats following repeated exposure to vanadyl sulfate and sodium orthovanadate via drinking water.
Harrington JM; Haines LG; Levine KE; Liyanapatirana C; Essader AS; Fernando RA; Robinson VG; Roberts GK; Stout MD; Hooth MJ; Waidyanatha S
Toxicol Appl Pharmacol; 2021 Feb; 412():115395. PubMed ID: 33421504
[TBL] [Abstract][Full Text] [Related]
3. Toxicity studies of sodium metavanadate and vanadyl sulfate administered in drinking water to Sprague Dawley (Hsd:Sprague Dawley SD) rats and B6C3F1/N mice.
National Toxicology Program
Toxic Rep Ser; 2023 Feb; (106):. PubMed ID: 36749982
[TBL] [Abstract][Full Text] [Related]
4. Characterization of aqueous formulations of tetra- and pentavalent forms of vanadium in support of test article selection in toxicology studies.
Mutlu E; Cristy T; Graves SW; Hooth MJ; Waidyanatha S
Environ Sci Pollut Res Int; 2017 Jan; 24(1):405-416. PubMed ID: 27726079
[TBL] [Abstract][Full Text] [Related]
5. 14-Day Toxicity Studies of Tetravalent and Pentavalent Vanadium Compounds in Harlan Sprague Dawley Rats and B6C3F1/N Mice via Drinking Water Exposure.
Roberts GK; Stout MD; Sayers B; Fallacara DM; Hejtmancik MR; Waidyanatha S; Hooth MJ
Toxicol Rep; 2016; 3():531-538. PubMed ID: 28042531
[TBL] [Abstract][Full Text] [Related]
6. Corrigendum to "Systemic exposure and urinary excretion of vanadium following perinatal subchronic exposure to vanadyl sulfate and sodium metavanadate via drinking water" [Toxicol. Lett. 360 (2022) 53-61].
Waidyanatha S; Weber FX; Fallacara DM; Harrington JM; Levine K; Robinson VG; Sparrow BR; Stout MD; Fernando R; Hooth MJ; Xie G; Roberts GK
Toxicol Lett; 2023 Jan; 373():210. PubMed ID: 36435680
[No Abstract] [Full Text] [Related]
7. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
Yuen VG; Orvig C; McNeill JH
Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of some chelating agents on distribution and excretion of vanadium in rats after prolonged oral administration.
Gómez M; Domingo JL; Llobet JM; Corbella J
J Appl Toxicol; 1991 Jun; 11(3):195-98. PubMed ID: 1918793
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the efficacy of various chelating agents on urinary excretion and tissue distribution of vanadium in rats.
Gomez M; Domingo JL; Llobet JM; Corbella J
Toxicol Lett; 1991 Jul; 57(2):227-34. PubMed ID: 1853367
[TBL] [Abstract][Full Text] [Related]
10. Accumulation and depletion of vanadium in selected tissues of rats treated with vanadyl sulfate and sodium orthovanadate.
Parker RD; Sharma RP
J Environ Pathol Toxicol; 1978; 2(2):235-45. PubMed ID: 739212
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of various vanadium salts on glucose homeostasis in streptozotocin-diabetic rats.
Becker DJ; Ongemba LN; Henquin JC
Eur J Pharmacol; 1994 Aug; 260(2-3):169-75. PubMed ID: 7988641
[TBL] [Abstract][Full Text] [Related]
12. Improvement of glucose homeostasis by oral vanadyl or vanadate treatment in diabetic rats is accompanied by negative side effects.
Domingo JL; Gómez M; Llobet JM; Corbella J; Keen CL
Pharmacol Toxicol; 1991 Apr; 68(4):249-53. PubMed ID: 1866388
[TBL] [Abstract][Full Text] [Related]
13. An assessment of the genotoxicity of vanadium.
Owusu-Yaw J; Cohen MD; Fernando SY; Wei CI
Toxicol Lett; 1990 Feb; 50(2-3):327-36. PubMed ID: 2309250
[TBL] [Abstract][Full Text] [Related]
14. Oral vanadium administration to streptozotocin-diabetic rats has marked negative side-effects which are independent of the form of vanadium used.
Domingo JL; Gomez M; Llobet JM; Corbella J; Keen CL
Toxicology; 1991 Mar; 66(3):279-87. PubMed ID: 1826377
[TBL] [Abstract][Full Text] [Related]
15. Effect of vanadium compounds on calmodulin activity in experimental diabetes in rats.
Aktan F; Nebioglu S
Can J Physiol Pharmacol; 1994 Jul; 72(7):753-8. PubMed ID: 7828083
[TBL] [Abstract][Full Text] [Related]
16. Vanadium compounds and cellular death mechanisms in the A549 cell line: The relevance of the compound valence.
Guerrero-Palomo G; Rendón-Huerta EP; Montaño LF; Fortoul TI
J Appl Toxicol; 2019 Mar; 39(3):540-552. PubMed ID: 30407648
[TBL] [Abstract][Full Text] [Related]
17. Administration of vanadyl sulfate by gavage does not normalize blood glucose levels in streptozotocin-induced diabetic rats.
Domingo JL; Sanchez DJ; Gomez M; Llobet JM; Corbella J
Res Commun Chem Pathol Pharmacol; 1992 Mar; 75(3):369-72. PubMed ID: 1509205
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like effect of vanadyl ion on streptozotocin-induced diabetic rats.
Sakurai H; Tsuchiya K; Nukatsuka M; Sofue M; Kawada J
J Endocrinol; 1990 Sep; 126(3):451-9. PubMed ID: 2170556
[TBL] [Abstract][Full Text] [Related]
19. Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends.
Ścibior A; Pietrzyk Ł; Plewa Z; Skiba A
J Trace Elem Med Biol; 2020 Sep; 61():126508. PubMed ID: 32305626
[TBL] [Abstract][Full Text] [Related]
20. Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV).
Willsky GR; Goldfine AB; Kostyniak PJ; McNeill JH; Yang LQ; Khan HR; Crans DC
J Inorg Biochem; 2001 May; 85(1):33-42. PubMed ID: 11377693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
